| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |